Total Return chart Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 15/01/2026			5-day change	1st Jan Change
210,500.00 ^KRW	-0.47%		-0.24%	+16.30%

01-14	Celltrion Presents Innovative Drug Pipeline and U.S. Manufacturing and R&D Expansion Strategy At the 44Th Annual J.P. Morgan Healthcare Conference	CI
01-06	Abpro, Celltrion Say Solid Cancer Tumor Therapy Investigational New Drug Application Receives US FDA Clearance	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.